Bifidogenic effect of fructooligosaccharides in the intestinal flora of patients with hematological neoplasia
Keywords:
bifidogenic microbiota, fructooligosaccharide, hematologic neoplasmsAbstract
Objective
To verify the bifidogenic effect of fructooligosaccharides in patients with hematological neoplasia submitted to chemotherapy.
Methods
This is a clinical, randomized, double-blind study done in the Bone Marrow Transplant Unit of the Oncology Research Center of Florianopolis. It involved 25 patients divided into 2 groups who received 12g of fructooligosaccharides (n=14) for 15 days or placebo (maltodextrin) (n=11). The amount of bifidobacteria and the values of fecal pH before and after supplementation were investigated.
Results
Most of the studied population was male (72%) and the mean age was 34 years. The group that received supplementation presented a significant increase in the amount of bifidobacteria (p<0.05) and fecal pH remained unchanged in both groups.
Conclusion
Supplementation increased the amount of bifidobacteria, interfering in the composition of the intestinal flora, but fecal pH was not affected.
References
Bourlioux P, Koletzko B, Guarner F, Braesco V. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium “The intelligent intestine”, held in Paris. Am J Clin Nutr. 2003; 78: 675-83.
Gibson GR, Roberfroid MB. Dietary modulation of human colonic microbiota: introducing the concept of the prebiotics. J Nutr. 1995; 125: 1401-12.
Berg R. The indigenous gastrointestinal microflora. Trends Microbiol. 1996; 4(11):430-5.
Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut. 1998; 42:2-7.
Blaut, M. Relationship of probiotics and food to intestinal microflora. Eur J Nutr. 2002; 41(Suppl 1):11-6.
Bengmark S. Immunonutrition: role of biosurfactants fiber and probiotic bacteria. Nutrition. 1998; 14(7/8):585-94.
Guarner F. El colon como órgano: hábitat de flora bacteriana. Nutr Hosp. 2002; (Suppl 2):2-7.
Peris GP, Lesmes B, Cuerda Compes CM, Álvarez C. Metabolismo colônico de la fibra. Nutr Hosp. 2002; 17:11-6.
Leahy SC, Higgins DG, Fitzgerald, Sinderen D van. A review: getting better with bifidobacterium. J Appl Microbiol. 2005; 98:1303-15.
Ishibashi N, Yaeshima T, Hayasawa H. Bifidobacteria: their significance in human intestinal health. Mal J Nutr. 1997; 3:149-59.
Guarner F, Malagelada JR. Gut flora in health and disease. The Lancet. 2003; 361(8):512-9.
Hopkins MJ, MacFarlane GT. Nondisgestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Appl Env Microbiol. 2003; 69(4):1920-7.
Gibson GR, Wang X. Regulatory effects of bifidobacteria on the growth of the colonic bacteria. J Appl Bacteriol. 1994; 77(4):412-20.
Gibson GR. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J Nutr. 1999; 129:1438-41s.
Nucci M. Infecções no paciente com neoplasia hematológica: diagnóstico, tratamento e prevenção. In: Zago MA, Falcão RP, Pasquini R. Hematologia: fundamentos e prática. São Paulo: Atheneu; 2001. cap.44:419-29.
Daly JM, Hoffman K, Lieberman M, Leon P, Redmond HP, Shou J, et al. Nutritional support in the cancer patient. JPEN. 1990; 14(5):244-8s.
Watzl B, Girrbacch S, Roller M. Inulin, oligofructose and immunomodulation. Br J Nutr. 2005; 93(Suppl 1): 49-55.
Cummings JH, Macfarlane GT, Englist HN. Prebiotics digestion and fermentation. Am J Clin Nutr. 2001; 73(Suppl):415-20.
Bengmark S, Lorenzo AG, Culebras MJ. Use of pro, pre and symbiotics in the ICU-future options. Nutr Hosp. 2001; 16(6):239-56.
Cummings JH, MacFarlane GT. Gastrointestinal effects of prebiotics. Br J Nutr. 2002; 87(Suppl 2):145-51.
Muñoa FJ, Pares R. Selective medium for isolation and enumeration of bifidobacterium spp. Appl Envl Microbiol. 1988; 54(7):1715-8.
Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, et al. Recombinant human interleukin 11 and bacterial infection in patient with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomized trial. Lancet. 2003; 361(25):275-80.
Bouhnik Y, Flourié B, Abensour DA, Pochart P, Gramet G, Durand M, et al. Administration transgalacto-oligosaccharides increases fecal bifidobactéria and modifies colonic fermentation metabolism in healthy humans. J Nutr. 1997; 127: 444-8.
Kleessen B, Sykura B, Zunfit HJ, Blaut M. Effect of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr. 1997; 65:1397-02.
Gibson GR. Fiber and effect on prebiotics (The prebiotic concept). Clin Nutr Suppl. 2004; 1:25-31.
Garro MS, Aguirre L, Giori GS. Biological activity of bifidobacterium longum in response to environmental pH. Appl Microbiol Biotechnol. 2005; (7):92-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Telma BÚRIGO, Regina Lúcia Martins FAGUNDES, Erasmo Benicio Santos de Moraes TRINDADE, Helena Cristina Ferreira Franz VASCONCELOS
This work is licensed under a Creative Commons Attribution 4.0 International License.
